CroíValve
PrivateLast Round
Series B
Jun 23, 2026
Total Funding Raised
$64.71M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CroíValve is a medical device company developing a minimally invasive transcatheter valve system for the treatment of tricuspid regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CroíValve Comparables
Compare CroíValve with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coramaze Technologies | 90% | |
| Trisol Medical | 89% | |
| VDyne | 89% |
CroíValve Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 23, 2026 | ||||
| Accelerator | Jul 2, 2025 | ||||
| Series B | Aug 7, 2024 | ||||
| Series A | Feb 4, 2022 | ||||
| VC Round | Sep 12, 2019 | ||||
Seed | Mar 28, 2019 |
CroíValve Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlantic Bridge Capital | Series B, Series A, Seed |
| European Innovation Council Fund | Accelerator |
| Furthr VC | Series B |
| IAG Capital Partners | Series B |
| Ascentifi | Series B, Series A |
| BGF | Series B |
| Dublin Business Innovation Centre | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 90% MoM.
- Sep 3, 2026
Grew 18% QoQ, from 50 to 59 employees.
Recent news
Latest coverage and updates
- is_developingSep 1, 2026
CroíValve Limited is developing novel approach to treating a serious heart condition.
- hiresJul 28, 2026
CroíValve Limited was planning to hire Jaime Wheeler as Chief Executive Officer on Jul 28th '26.
- hiresJul 28, 2026
CroíValve Limited hires Lucy O'Keeffe as COO.
- hiresJul 28, 2026
CroíValve Limited hired Jaime Wheeler as Chief Executive Officer on Jul 28th '26.
CroíValve Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CroíValve's valuation, stock price, and market status.
Is CroíValve a public or private company?
CroíValve is a private company.
What is the current stock price of CroíValve?
CroíValve is a private company, so its shares have no public market price. Caplight tracks CroíValve's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CroíValve worth (valuation)?
Valuation information for CroíValve is not publicly available.
Can I buy CroíValve stock?
CroíValve shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CroíValve's last funding round?
CroíValve's most recent funding round was Series B on June 23, 2026.
Who are the main investors in CroíValve?
Key investors in CroíValve include Irrus Investments, The MedTech Syndicate.
Will CroíValve IPO soon?
No public IPO plans have been announced for CroíValve.
How can I track CroíValve secondary market activity?
Caplight tracks bids, offers, and trades in CroíValve's shares on secondary markets.